Published in BMJ on March 13, 1993
Prescribing antidepressants in general practice. BMJ (1996) 4.79
Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. BMJ (1994) 4.67
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ (2006) 4.42
Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ (1995) 3.83
New antidepressants for old people? BMJ (1999) 2.71
Guidelines, enthusiasms, uncertainty, and the limits to purchasing. BMJ (1995) 2.59
[Antidepressants for treatment of depression in palliative patients : a systematic literature review]. Schmerz (2012) 2.04
Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med (2005) 2.03
Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health (1997) 1.83
An exploratory mixed methods study of the acceptability and effectiveness of Mindfulness-Based Cognitive Therapy for patients with active depression and anxiety in primary care. BMC Psychiatry (2006) 1.61
Which antidepressant? A commentary from general practice on evidence-based medicine and health economics. Br J Gen Pract (1997) 1.54
Prescription of antidepressants by general practitioners: recommendations by FHSAs and health boards. Br J Gen Pract (1996) 1.40
Mental health policy and psychotropic drugs. Milbank Q (2005) 1.38
Newer antidepressants: a comparison of tolerability in general practice. Br J Gen Pract (1999) 1.09
Which antidepressants are best tolerated in primary care? A pilot randomized trial from goa. Indian J Psychiatry (1999) 1.07
Serotonin transporters: implications for antidepressant drug development. AAPS J (2005) 1.02
Effective and acceptable treatment for depression. BMJ (1993) 0.96
Effective and acceptable treatment for depression. BMJ (1993) 0.88
Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy. Clin Trials (2009) 0.86
Family interventions in schizophrenia. BMJ (1996) 0.85
A systematic review of conflicting meta-analyses in orthopaedic surgery. Clin Orthop Relat Res (2009) 0.84
Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment. Psychol Res Behav Manag (2011) 0.82
New or old antidepressants? Benefits of new drugs are exaggerated. BMJ (1994) 0.80
Meta-analysis of antidepressant prescribing. Drop out rates presented in a misleading manner. BMJ (1995) 0.79
A systematic review of Chinese randomized clinical trials of SSRI treatment of depression. BMC Psychiatry (2014) 0.76
Antidepressants and suicide. Study's conclusion is unwarranted. BMJ (1995) 0.75
Selective serotonin reuptake inhibitors. Total profile of drug should be considered. BMJ (1994) 0.75
Selective serotonin reuptake inhibitors. Authors' assumptions are misleading. BMJ (1994) 0.75
Effective and acceptable treatment for depression. BMJ (1993) 0.75
Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial. Clin Pharmacol (2012) 0.75
Deciding which selective serotonin reuptake inhibitor to prescribe. BMJ (1995) 0.75
Meta-analysis of antidepressant prescribing. Acceptability of side effects as reason for stopping may bias results. BMJ (1995) 0.75
Effective and acceptable treatment for depression. BMJ (1993) 0.75
Sertraline-induced agranulocytosis. Postgrad Med J (1996) 0.75
Improving adherence to sertraline treatment: the effectiveness of a patient education intervention. Prim Care Companion J Clin Psychiatry (2006) 0.75
Effective and acceptable treatment for depression. BMJ (1993) 0.75
The ideal: enemy of the useful? Qual Health Care (1995) 0.75
Effective and acceptable treatment for depression. BMJ (1993) 0.75
Antidepressants for old people. GPs should become familiar with one or two antidepressants from each class. BMJ (1999) 0.75
Selective serotonin reuptake inhibitors. Methodology is inadequately described. BMJ (1994) 0.75
Misleading meta-analysis. Subject to many potential biases. BMJ (1995) 0.75
Effective and acceptable treatment for depression. BMJ (1993) 0.75
Will the new antipsychotics improve the treatment of schizophrenia? BMJ (1993) 0.75
Mood Disorders in Neurologic Illness. Curr Treat Options Neurol (2000) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 22.39
Recognition and management of depression in general practice: consensus statement. BMJ (1992) 11.22
Selective serotonin reuptake inhibitors. BMJ (1992) 2.58
Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry (1990) 2.12
Enhancing effective and acceptable purchaser and provider decisions: overview and methods. Qual Health Care (1992) 1.97
A comparison of statistical methods for combining event rates from clinical trials. Stat Med (1989) 1.95
A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry (1985) 1.53
Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry (1990) 1.40
The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo. Psychopharmacol Bull (1989) 1.34
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. J Clin Psychiatry (1985) 1.32
A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients. J Affect Disord (1984) 1.25
A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder. Br J Clin Pract (1988) 1.24
A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. Int Clin Psychopharmacol (1989) 1.22
A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. J Clin Psychiatry (1985) 1.20
A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J Clin Psychiatry (1985) 1.17
A placebo- and imipramine-controlled study of paroxetine. Psychopharmacol Bull (1990) 1.16
Fluoxetine versus trazodone in depressed geriatric patients. J Geriatr Psychiatry Neurol (1990) 1.15
A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients. Acta Psychiatr Scand (1988) 1.14
Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry (1985) 1.13
Double-blind comparison of bupropion and fluoxetine in depressed outpatients. J Clin Psychiatry (1991) 1.12
Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline. Int Clin Psychopharmacol (1992) 1.11
Paroxetine in the treatment of depression--a randomized comparison with amitriptyline. Acta Psychiatr Scand (1985) 1.08
A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients. Br J Clin Pract (1991) 1.07
Treatment of major affective disorder with fluvoxamine. J Clin Psychiatry (1987) 1.06
A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression. Prog Neuropsychopharmacol Biol Psychiatry (1990) 1.03
Fluoxetine in depressed patients: a comparison with imipramine. J Clin Psychiatry (1984) 1.03
A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice. Int Clin Psychopharmacol (1989) 1.03
A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. J Clin Psychiatry (1985) 1.02
A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Acta Psychiatr Scand Suppl (1989) 1.00
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry (1992) 0.97
Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study. J Clin Psychiatry (1991) 0.97
A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression. J Clin Psychiatry (1990) 0.97
Fluoxetine efficacy vs comparative drugs: an overview. Br J Psychiatry Suppl (1988) 0.96
Fluoxetine versus trazodone in the treatment of outpatients with major depression. J Clin Psychiatry (1988) 0.96
Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial. Int J Clin Pharmacol Res (1989) 0.95
A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression. Pharmacopsychiatry (1991) 0.95
A comparative trial of fluoxetine versus trazodone in outpatients with major depression. J Clin Psychiatry (1989) 0.95
A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline. Acta Psychiatr Scand Suppl (1989) 0.95
Fluoxetine, a highly selective serotonin reuptake inhibitor: a review of preclinical studies. Br J Psychiatry Suppl (1988) 0.94
A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders. Int Clin Psychopharmacol (1989) 0.93
Fluoxetine versus clomipramine in major depressive disorders. Int Clin Psychopharmacol (1989) 0.93
A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients. Acta Psychiatr Scand Suppl (1989) 0.93
Fluoxetine vs amitriptyline in the treatment of depressed out-patients. Br J Psychiatry Suppl (1988) 0.93
A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group. Int Clin Psychopharmacol (1992) 0.93
A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. Psychopharmacol Bull (1984) 0.93
A controlled comparison of fluoxetine and amitriptyline in depressed out-patients. Br J Psychiatry (1987) 0.92
Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Curr Med Res Opin (1990) 0.91
Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression. Pharmacopsychiatry (1991) 0.91
A comparative trial of a new antidepressant, fluoxetine. Br J Psychiatry (1987) 0.91
Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders. Int Clin Psychopharmacol (1989) 0.90
Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements. Acta Psychiatr Scand (1991) 0.90
Fluoxetine versus imipramine. Int Clin Psychopharmacol (1989) 0.90
Sleep and paroxetine: a comparison with mianserin in elderly depressed patients. Int Clin Psychopharmacol (1992) 0.89
Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders. Int Clin Psychopharmacol (1989) 0.89
Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people. Acta Psychiatr Scand (1991) 0.89
Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder. Int Clin Psychopharmacol (1989) 0.89
A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness. Curr Med Res Opin (1990) 0.89
Meta-analysis and multiple publication of clinical trial reports. Lancet (1992) 0.89
Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin. Acta Psychiatr Scand (1988) 0.89
Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders. Int Clin Psychopharmacol (1989) 0.88
A double-blind study of fluoxetine and imipramine in major depression. Int Clin Psychopharmacol (1989) 0.88
A multicentre open trial of fluoxetine in depressed out-patients in Belgium. Int Clin Psychopharmacol (1989) 0.86
Catching goldfish: quality in qualitative research. J Health Serv Res Policy (1998) 34.08
The use of statins: a case of misleading priorities? BMJ (1997) 13.35
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology (1999) 11.94
A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst (1973) 10.64
Qualitative research methods in health technology assessment: a review of the literature. Health Technol Assess (1998) 9.45
Information needs and decisional preferences in women with breast cancer. JAMA (1997) 7.46
Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2007) 7.25
Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2001) 7.24
Communications between general practitioners and consultants. Br Med J (1974) 7.18
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ (2000) 6.67
Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet (1991) 6.61
Developing and implementing clinical practice guidelines. Qual Health Care (1995) 6.52
Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ (1993) 6.23
WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database Syst Rev (2007) 6.02
beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ (1999) 5.66
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. BMJ (1994) 4.67
Routinely administered questionnaires for depression and anxiety: systematic review. BMJ (2001) 4.54
North of England evidence based guidelines development project: guideline for the primary care management of dementia. BMJ (1998) 4.39
Please bypass the PORT. BMJ (1994) 4.37
Homicides and suicides by mentally ill people. BMJ (1996) 4.33
Allocating resources to health authorities: results and policy implications of small area analysis of use of inpatient services. BMJ (1994) 4.17
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J (2003) 4.09
Allocating resources to health authorities: development of method for small area analysis of use of inpatient services. BMJ (1994) 3.88
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology (1993) 3.76
Management of deliberate self poisoning in adults in four teaching hospitals: descriptive study. BMJ (1998) 3.68
Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate. BMJ (1999) 3.60
A survey of job satisfaction, sources of stress and psychological symptoms among general practitioners in Leeds. Br J Gen Pract (1998) 3.57
Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut (2004) 3.55
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci (2001) 3.50
Promoting cost effective prescribing. BMJ (1995) 3.46
Modelling in economic evaluation: an unavoidable fact of life. Health Econ (1997) 3.40
HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res (2001) 3.27
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst (1999) 3.26
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res (1994) 3.25
North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. BMJ (1998) 3.14
Volume and outcome in coronary artery bypass graft surgery: true association or artefact? BMJ (1995) 3.12
Somatoform disorders: severe psychiatric illnesses neglected by psychiatrists. Br J Psychiatry (2001) 3.06
Cost effectiveness of antenatal screening for cystic fibrosis. BMJ (1995) 3.05
Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 3.04
Evidence-informed patient choice. Practical issues of involving patients in decisions about health care technologies. Int J Technol Assess Health Care (1998) 2.95
Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years. BMJ (2009) 2.95
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ (2000) 2.92
Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer (2001) 2.82
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J (2003) 2.78
Screening and case finding instruments for depression. Cochrane Database Syst Rev (2005) 2.67
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet (2002) 2.61
A systematic review of compression treatment for venous leg ulcers. BMJ (1997) 2.61
A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer (1997) 2.53
Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat (1988) 2.51
Something rotten in the state of clinical and economic evaluations? Health Econ (1994) 2.50
Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol (1998) 2.47
Comparison of physical treatments versus a brief pain-management programme for back pain in primary care: a randomised clinical trial in physiotherapy practice. Lancet (2005) 2.43
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
Shared care in diabetes. BMJ (1995) 2.39
A comparison of costs and data quality of three health survey methods: mail, telephone and personal home interview. Am J Epidemiol (1986) 2.36
Screening for enteropathogenic Escherichia coli in infants with diarrhea by the fluorescent-actin staining test. Infect Immun (1991) 2.35
Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol (2002) 2.34
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (1996) 2.33
Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 2.33
Increasing incidence of breast cancer in family with BRCA1 mutation. Lancet (1993) 2.33
Two infant vision screening programmes: prediction and prevention of strabismus and amblyopia from photo- and videorefractive screening. Eye (Lond) (1996) 2.25
Structural basis for the excision repair of alkylation-damaged DNA. Cell (1996) 2.23
Deliberate self harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition. BMJ (1998) 2.23
Surgically induced necrotising sclerokeratitis (SINS)--precipitating factors and response to treatment. Br J Ophthalmol (1992) 2.22
The efficacy of problem-solving treatments after deliberate self-harm: meta-analysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems. Psychol Med (2001) 2.22
Genetic instability of microsatellites in endometrial carcinoma. Cancer Res (1993) 2.20
EUR-ASSESS Project Subgroup Report on Dissemination and Impact. Int J Technol Assess Health Care (1997) 2.18
Psychosocial versus pharmacological treatments for deliberate self harm. Cochrane Database Syst Rev (2000) 2.18
Informed choice for users of health services: views on ultrasonography leaflets of women in early pregnancy, midwives, and ultrasonographers. BMJ (1996) 2.16
The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord (1997) 2.10
When is it cost-effective to change the behavior of health professionals? JAMA (2001) 2.08
Carcinogenic activity of bracken. Nature (1965) 2.03
How to develop cost-conscious guidelines. Health Technol Assess (2001) 2.03
Systematic reviews of trials and other studies. Health Technol Assess (1998) 1.99
Enhancing effective and acceptable purchaser and provider decisions: overview and methods. Qual Health Care (1992) 1.97
A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. Health Technol Assess (2000) 1.96
Facial dyskinesia: a 16-year follow-up study. Br J Psychiatry (1991) 1.94
Crucial importance of PKC-beta(I) in LFA-1-mediated locomotion of activated T cells. Nat Immunol (2001) 1.94
DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med (1993) 1.91
The early repetition of deliberate self harm. J R Coll Physicians Lond (1997) 1.90
Depression after stroke and lesion location: a systematic review. Lancet (2000) 1.87
Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome. Br J Psychiatry (1998) 1.86
The evidence for beta blockers in heart failure. BMJ (1999) 1.84